Knight Therapeutics (KHTRF) Q3 2025 Earnings

7AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.1
-0.04
0.02
0.08

Details

Expected EPS
0.0136741865
Actual EPS
-0.095485
Surprise EPS
-0.11
Surprise Percent
+798.29%

Description

Knight Therapeutics (KHTRF) has reported earnings of -0.095485 per share for Q3 2025.

0 Comments

Share your thoughts